Cellevolve Bio News Today

/PRNewswire/ -- cTRL Therapeutics, a biotechnology company harnessing circulating tumor-reactive lymphocytes (cTRLs) in the blood to broaden the power and...

The global progressive multifocal leukoencephalopathy treatment market is expected to garner a market value of US$ 1,320 million in 2023 and is expected to accumulate a market value of US$ 1,773.97 million by registering a CAGR of 3% in the forecast period 2023 to 2033. The market for progressive multifocal leukoenc...

/PRNewswire/ -- Cellevolve Bio, Inc. ("the Company" or "Cellevolve"), a clinical stage development and commercialization platform company focused on cell...

/PRNewswire/ -- Cellevolve Bio, Inc. ("the Company" or "Cellevolve"), a development and commercialization platform company focused on cell therapies, today...

Black students are a minority in the life sciences and biotechnology. A Black female scientist and entrepreneur talks about why and how this should change.

Press release content from Business Wire. The AP news staff was not involved in its creation.

A new investment fund launched by one of the few Black venture capitalists in health care is focused on backing Black entrepreneurs. And the investors include some of the biggest names in for-profit health care.

A new investment fund launched by one of the few Black venture capitalists in health care is focused on backing Black entrepreneurs. And the investors include some of the biggest names in for-profit health care.

Marcus Whitney stands out in Nashville's $95 billion health care sector as an investor in startups. In addition to co-founding a venture capital firm, he's organized an annual health tech conference and co-founded the city's professional soccer club.

A new investment fund launched by one of the few Black venture capitalists in health care is focused on backing Black entrepreneurs. And the investors include some of the biggest names in for-profit health care.